Signet Therapeutics
Boston, United States · $10.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Website
- en.signettx.com
- Total Funding
- $10.0M
- Last Round
- Series AJan 2026
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Signet Therapeutics is a clinical-stage biotech developing first-in-class targeted cancer therapies using patient-derived organoids and AI-powered drug discovery.
Summary
Signet Therapeutics is an Artificial Intelligence company based in Boston, United States. It has raised $10.0M in total across 2 rounds, most recently a Series A round in Jan 2026. Investors include Tiantu Capital, 5Y Capital and Green Pine Capital Partners.
Funding History
Jan 2026
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Databricks provides a unified data and AI platform that helps enterprises build and run applicati...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/signet-therapeutics"><img src="https://indexed.vc/api/badge/company/signet-therapeutics" alt="Signet Therapeutics on Indexed.vc" width="260" height="76" /></a>